ArticleChemistry, an Asian journal2026
Synthesis, Characterization, and Colorimetric Sensing of Zr
Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Here, we put forth the synthesis, characterization of 2,3-diphenyl-5,6,7,8-tetrahydroquinoxaline stabilized silver nanoparticles (AgNPs) DTQ@AgNPs by a coprecipitation method. Additionally, Schiff base is employed as an N, N-donor ligand to regulate the shape of NPs. The effective production and stability of the nanocomposite were validated by extensive morphological (SEM, TEM, and XRD), thermal (TGA and DTG), and spectroscopic (UV-visible, FTIR, NMR, and fluorescence) investigations. DTQ@AgNPs acts as a dual-mode chemosensor for the sensitive and selective colorimetric detection of Zr⁴⁺ and fluorometric detection of Cd
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.